Clinical trials
Observational Epilepsy trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
37 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2014 | 1 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 4 |
| 2020 | 1 |
| 2021 | 6 |
| 2022 | 6 |
| 2023 | 3 |
| 2024 | 4 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 15 |
| Recruiting | 10 |
| Completed | 8 |
| Active, not recruiting | 3 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 6 |
| Beijing Children's Hospital | 4 |
| Children's Hospital of Fudan University | 4 |
| Shanghai Zhongshan Hospital | 2 |
| Shen Chun-Hong | 2 |
| Xuanwu Hospital, Beijing | 2 |
| Affiliated Hospital of Jiangnan University | 1 |
| Beijing Neurosurgical Institute | 1 |
| Guangzhou Women and Children's Medical Center | 1 |
| Istituto Giannina Gaslini | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Epilepsy | 37 |
| Seizures | 7 |
| Autoimmune Diseases of the Nervous System | 2 |
| Brain Neoplasms | 2 |
| Tuberous Sclerosis | 2 |
| Acute Coronary Syndrome | 1 |
| Alzheimer Disease | 1 |
| Attention Deficit Disorder with Hyperactivity | 1 |
| Autistic Disorder | 1 |
| Brain Injuries, Traumatic | 1 |
Trials
Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.